Biodesix Inc. (BDSX)
NASDAQ · Healthcare
Biodesix Inc. EBITDA 2019–2025
Biodesix Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Biodesix Inc. ebitda for the quarter ending March 31, 2026 was -4.8 M, a 37.56% decrease year-over-year.
- Biodesix Inc. ebitda for the twelve months ending March 31, 2026 was -26.4 M, a 32.43% decrease year-over-year.
- Biodesix Inc. annual ebitda for 2025 was -22.2 M, a 22.70% decrease from 2024.
- Biodesix Inc. annual ebitda for 2024 was -28.7 M, a 24.44% decrease from 2023.
- Biodesix Inc. annual ebitda for 2023 was -38.0 M, a 19.10% decrease from 2022.
- Biodesix Inc. annual ebitda for 2022 was -47.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Biodesix Inc. EBITDA — FAQ
Biodesix Inc. (BDSX) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BDSX's ebitda history?
The chart and table above show Biodesix Inc.'s ebitda by year and by quarter, including the growth rate.